Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen
- PMID: 6652973
- PMCID: PMC1536166
Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen
Abstract
The response of BALB/c mice to immunization with a 230,000 mol. wt protective antigen purified from the blood stages of Plasmodium yoelii was analysed. The protective response to immunization was adjuvant-dependent, and saponin was found to be the most effective adjuvant tested. The intraperitoneal route was found to be superior to the subcutaneous route for protective immunization. Maximal protection was achieved using two immunizations with greater than 12.5 micrograms of antigen plus saponin, but even under these conditions challenge infection developed normally for 5 days, followed by the appearance of crisis forms and rapid clearance of parasites. Effective immunization induced high antibody titres, but serum from immunized mice was not protective on passive transfer. On the other hand, hyperimmune serum from mice recovered and rechallenged with live P. yoelii was protective on passive transfer, even though the titre of antibody specific for the 230,000 mol. wt antigen in this serum was the same as that in the serum from mice immunized with the purified antigen. It was concluded that the 230,000 mol. wt antigen may provide protection against P. yoelii via the cell-mediated immune effector pathway described by Playfair et al. (1979), and that hyperimmune serum contains protective antibodies specific for P. yoelii antigens other than the 230,000 mol. wt antigen.
Similar articles
-
Passive immunization against murine malaria with an IgG3 monoclonal antibody.J Immunol. 1984 Jun;132(6):3131-7. J Immunol. 1984. PMID: 6725950
-
Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.J Immunol. 1997 Oct 1;159(7):3400-11. J Immunol. 1997. PMID: 9317139
-
Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB/c mice.Vaccine. 2007 Mar 1;25(11):2103-11. doi: 10.1016/j.vaccine.2006.11.023. Epub 2006 Nov 27. Vaccine. 2007. PMID: 17241709
-
Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.Exp Parasitol. 1999 Jan;91(1):78-85. doi: 10.1006/expr.1999.4357. Exp Parasitol. 1999. PMID: 9920045
-
Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.Clin Vaccine Immunol. 2007 Apr;14(4):342-7. doi: 10.1128/CVI.00397-06. Epub 2007 Feb 21. Clin Vaccine Immunol. 2007. PMID: 17314232 Free PMC article.
Cited by
-
Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens.Infect Immun. 1992 May;60(5):1894-901. doi: 10.1128/iai.60.5.1894-1901.1992. Infect Immun. 1992. PMID: 1563780 Free PMC article.
-
Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant.Infect Immun. 1996 Sep;64(9):3532-6. doi: 10.1128/iai.64.9.3532-3536.1996. Infect Immun. 1996. PMID: 8751895 Free PMC article.
-
Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity.Clin Exp Immunol. 1985 Oct;62(1):19-23. Clin Exp Immunol. 1985. PMID: 2933196 Free PMC article.
-
Roles of the Maltese cross form in the development of parasitemia and protection against Babesia microti infection in mice.Infect Immun. 2003 Jan;71(1):411-7. doi: 10.1128/IAI.71.1.411-417.2003. Infect Immun. 2003. PMID: 12496191 Free PMC article.
-
Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice.Clin Exp Immunol. 1987 Jan;67(1):5-10. Clin Exp Immunol. 1987. PMID: 3113784 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical